A Double-Blind, Randomized, Placebo-Controlled, Phase II Clinical Study To Evaluate the Efficacy and Safety of Camostat Mesylate (DWJ1248) in Adult Patients with Mild to Moderate COVID-19
一项双盲、随机、安慰剂对照的II期临床研究，旨在评估卡莫司他甲磺酸盐（DWJ1248）治疗轻度至中度COVID-19成年患者的疗效和安全性。
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.00452-22
Kim, Yeon-Sook; Jeon, Seng-Ho; Kim, Junghee; Koh, Jong Hoon; Ra, Seung Won; Kim, Ji Won; Kim, Yeonjae; Kim, Choon Kwan; Shin, Yun Chul; Kang, Beo Deul; Kang, Seung Ji; Park, Chul Hee; Lee, Boyoung; Lee, Ji Yeon; Lee, Chung Hoon; Choi, Jae-Phil; Kim, Jin Yong; Yu, Shi Nae; Peck, Kyong Ran; Kim, Sung-Han; Heo, Jung Yeon; Kim, Hyun Ah; Park, Hyun-Jin; Choi, Jongwon; Han, Jumi; Kim, JooHyun; Kim, Hyoung Jun; Han, Se Hee; Yoon, Aeri; Park, MiHee; Park, SuJung; Kim, YuKyung; Jung, Minji; Oh, Myoung-Don
